An open, randomised, single center study to compare a low suction intra and postoperative autologous blood transfusion system with no drainsystem at all with regards to haemoglobin loss following primary total hip arthroplasty implantation

An open, randomised, single center study to compare a low suction intra and postoperative autologous blood transfusion system with no drainsystem at all with regards to haemoglobin loss following primary total hip arthroplasty implantation - Comparison of a bloodtransfusion system with no drain, during hipsurgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON32927

Enrollment

214

Registered

2009-04-09

Start date

2009-08-03

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip replacement operation total hip arthroplasty

Interventions

for summary see the dutch version above

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age 18 years and up provision of written informed consent the patient is subject to a total hip arthroplasty implantation

Exclusion criteria

Exclusion criteria: coagulation disorders, including thrombo embolic history malignancy ongoing infections untreated hypertension renal dysfunction unstable angina pectoris myocardial infarction within the past 12 months bypass-operation within the past 12 months intake of anticoagulants participation in other clinical trials dealing with any drugs which influences blood loss

Design outcomes

Primary

Measure	Time frame
for summary see the dutch version above	—

Secondary

Measure	Time frame
for summary see the dutch version above	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)